ストックスクリーナーアプリを入手
29.28
1.25%
-0.37
プレマーケット:
29.25
-0.03
-0.10%
Mineralys Therapeutics Inc (MLYS) 最新ニュース
Mineralys Therapeutics reports inducement awards under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Two new Mineralys hires get stock options and RSUs under Nasdaq rule - Stock Titan
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Mineralys to Report First-Quarter Results on May 6 - MyChesCo
Mineralys Therapeutics Advances Drug Commercialization Through Comprehensive Contract Support - Faegre Drinker
Mineralys fireside chat at Bank of America conference streams May 12 - Stock Titan
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference - marketscreener.com
Is Mineralys Therapeutics, Inc. (MLYS) A Good Stock To Buy Now? - Insider Monkey
(MLYS) Volatility Zones as Tactical Triggers - Stock Traders Daily
Mineralys Therapeutics (MLYS) Projected to Post Earnings on Wednesday - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Trading 8.2% HigherShould You Buy? - MarketBeat
Why Mineralys Therapeutics Stock Is Surging Today - TipRanks
Mineralys Therapeutics, Inc. $MLYS Shares Bought by Jennison Associates LLC - MarketBeat
Pictet Asset Management Holding SA Sells 76,286 Shares of Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 - Yahoo Finance
Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap DownHere's Why - MarketBeat
TD Cowen initiates coverage of Mineralys Therapeutics (MLYS) with buy recommendation - MSN
Mineralys Therapeutics stock initiated at buy by TD Cowen on drug potential - Investing.com Nigeria
TD Cowen Initiates Mineralys Therapeutics(MLYS.US) With Buy Rating - Moomoo
Mineralys Therapeutics (MLYS) Appoints Jeffrey A. Munsie as Chief Legal Officer - Insider Monkey
10 Best New Stocks to Invest In According to Hedge Funds - Insider Monkey
MLYS Price Today: Mineralys Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Price-Driven Insight from (MLYS) for Rule-Based Strategy - Stock Traders Daily
Mineralys Therapeutics CMO Rodman sells $13,033 after option exercise By Investing.com - Investing.com Australia
David Malcom Rodman Sells 416 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat
Mineralys Therapeutics CMO Rodman sells $13,033 after option exercise - Investing.com
Mineralys (MLYS) CMO logs small 10b5-1 share sale and option exercise - Stock Titan
Why Mineralys Therapeutics Shares Are Sliding Now - TipRanks
Mineralys Therapeutics (MLYS) Stock Underperform Rating (Modest Decline) 2026-04-20Price Action - Xã Thanh Hà
Mineralys Therapeutics (MLYS) Stock: Why Pricing Increase (Idled) 2026-04-18Expert Insights - Xã Vĩnh Công
416-share cashless exercise reported by Mineralys (NASDAQ: MLYS) - Stock Titan
David Malcom Rodman Sells 14,058 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat
Mineralys (MLYS) CMO exercises options and sells 20,406 shares in 10b5-1 trades - Stock Titan
Mineralys CEO sells 15,730 shares under 10b5-1 plan | MLYS Insider Trading - Stock Titan
Congleton, Mineralys Therapeutics CEO, sells $421k in MLYS stock By Investing.com - Investing.com Canada
Mineralys Therapeutics (MLYS) CMO Rodman sold $548k in shares By Investing.com - Investing.com Canada
MLYS Stock Climbs As FDA Review And New CLO Draw Trader Focus - timothysykes.com
David Rodman sells shares; Mineralys Therapeutics (NASDAQ: MLYS) Form 144 listing - Stock Titan
Mineralys Therapeutics (NASDAQ:MLYS) Shares Up 10.5%Still a Buy? - MarketBeat
Mineralys therapeutics MLYS: Chief medical officer sells $59k in shares By Investing.com - Investing.com South Africa
Mineralys therapeutics MLYS: Chief medical officer sells $59k in shares - Investing.com India
Mineralys Therapeutics (NASDAQ:MLYS) Insider David Malcom Rodman Sells 2,170 Shares - MarketBeat
Mineralys (MLYS) CMO exercises options and sells 2,170 shares under 10b5-1 plan - Stock Titan
Mineralys Therapeutics (NASDAQ: MLYS) insider sales and RSU vesting disclosed - Stock Titan
Affiliate sale of 14,058 shares and multiple David Rodman trades (MLYS) - Stock Titan
(MLYS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Sentiment Recap: Whats the profit margin of Mineralys Therapeutics Inc2026 Key Highlights & Daily Profit Maximizing Tips - baoquankhu1.vn
[ARS] Mineralys Therapeutics, Inc. SEC Filing - Stock Titan
Aug Catalysts: What is Mineralys Therapeutics Incs revenue forecastQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Retail Trends: What are the future prospects of Mineralys Therapeutics Inc2026 Sentiment & Community Shared Stock Ideas - baoquankhu1.vn
Mineralys Therapeutics (MLYS) Rule 144: Director sales and 2,170-share cashless exercise - Stock Titan
Form DEFA14A Mineralys Therapeutics, - StreetInsider
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):